Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit
- PMID: 12829660
- DOI: 10.1200/JCO.2003.03.039
Maintenance therapy in advanced ovarian cancer: progression-free survival and clinical benefit
Comment on
-
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial.J Clin Oncol. 2003 Jul 1;21(13):2460-5. doi: 10.1200/JCO.2003.07.013. J Clin Oncol. 2003. PMID: 12829663 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
